Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early hGH Treatment of Symmetrically Born SGA Infants
NCT02326610Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 2 trial of somatropin in Small for gestational age (SGA), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
somatropin
03
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT02326610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02326610.